SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection

Non-alcoholic fatty liver disease (NAFLD) is an ‘umbrella’ term, comprising a spectrum ranging from benign, liver steatosis to non-alcoholic steatohepatitis, liver fibrosis and eventually cirrhosis and hepatocellular carcinoma. NAFLD has evolved as a major health problem in recent years. Discovering...

Descripción completa

Detalles Bibliográficos
Autores principales: Androutsakos, Theodoros, Nasiri-Ansari, Narjes, Bakasis, Athanasios-Dimitrios, Kyrou, Ioannis, Efstathopoulos, Efstathios, Randeva, Harpal S., Kassi, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953901/
https://www.ncbi.nlm.nih.gov/pubmed/35328527
http://dx.doi.org/10.3390/ijms23063107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953901/
https://www.ncbi.nlm.nih.gov/pubmed/35328527
http://dx.doi.org/10.3390/ijms23063107

Ejemplares similares